Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.89
+0.45 (+0.36%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
69
70
Next >
Germany's Possible Export Ban On Semiconductor Chemicals To China: What It Means For The U.S
April 27, 2023
Via
Benzinga
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
April 27, 2023
The FDA's Oncologic Drugs Advisory Committee will be meeting tomorrow, Friday, 28 April, to discuss the supplemental new drug application (sNDA) for Lynparza (olaparib) in combination with abiraterone...
Via
Benzinga
Why Merck Stock Is Trading Higher Today
April 27, 2023
Merck & Co Inc's (NYSE: MRK) Q1 sales reached $14.49 bi
Via
Benzinga
2 of These 3 Stocks Are Lifting the Dow, but 1 Is Holding It Back
April 27, 2023
Earnings season is approaching its peak.
Via
The Motley Fool
Merck Makes a Bold Move That Could Transform Its Business
April 27, 2023
It's a risky deal for Merck, but it could pay off significantly.
Via
The Motley Fool
Here's How Much $100 Invested In Merck & Co 5 Years Ago Would Be Worth Today
April 21, 2023
Via
Benzinga
This Is What Whales Are Betting On Merck & Co
April 19, 2023
Via
Benzinga
Merck: Surpasses Q1 Earnings And Revenue Estimates
April 27, 2023
Merck came out with quarterly earnings of $1.40 per share.
Via
Talk Markets
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
April 27, 2023
Tech earnings could come to the market’s rescue on Thursday, with all major index futures currently trading higher.
Via
Benzinga
Will Merck's Earnings Beat Give The Pharma Stock A Sorely Needed Boost?
April 27, 2023
The company reported lighter-than-expected declines due to Keytruda and Gardasil.
Via
Investor's Business Daily
The 7 Best Stocks From Schwab’s Dividend ETF
April 26, 2023
Investors may beat the market by cherry-picking the best dividend stocks from the Schwab income exchange-traded fund.
Via
InvestorPlace
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
Biotech is expected to be a hotbed of mergers and acquisitions this year.
Via
The Motley Fool
This Supercharged Dividend King Stock Might Soon Run Out of Steam
April 25, 2023
Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker's growth trajectory post-2025.
Via
The Motley Fool
3 Pharma Stocks That Could See a Surge in Demand in 2023
April 24, 2023
These pharma stocks to buy are poised for long-term growth in the trillion-dollar biotechnology space, offering tremendous upside ahead
Via
InvestorPlace
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
April 21, 2023
The Pan American Health Organization (PAHO) is reportedly in early talks with Takeda Pharmaceutical Co Ltd (NYSE: TAK) regarding the potential orders of its dengue vaccine, TAK-003.
Via
Benzinga
Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review
April 21, 2023
The major indexes saw modest declines, holding in a range.
Via
Investor's Business Daily
Why Prometheus Biosciences Stock Is Skyrocketing This Week
April 20, 2023
There's nothing like a big buyout to send a clinical-stage biotech stock soaring higher.
Via
The Motley Fool
Why Shares of Bellus Health Skyrocketed This Week
April 20, 2023
The company has received a buyout offer from GSK.
Via
The Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
April 20, 2023
Two key tailwinds fueled a surge in the biotech's share price this week.
Via
The Motley Fool
These 2 Growth Stocks Might Be Incredibly Undervalued Right Now
April 20, 2023
These two biopharma stocks could be poised for a major growth spurt.
Via
The Motley Fool
Is Moderna About to Face the Same Challenge as Other Biotechs?
April 20, 2023
Investors have gotten used to Moderna's rapid vaccine development.
Via
The Motley Fool
Genprex Touts Encouraging Preclinical Data From Lung Cancer Candidate
April 19, 2023
Genprex Inc (NASDAQ: GNPX) announced that its research collaborators presented preclinical data for the NPRL2 gene (also known as the TUSC4 gene).
Via
Benzinga
Is Merck Stock a Screaming Buy After This $11 Billion Acquisition?
April 19, 2023
Merck's move into immunology is a risky proposition.
Via
The Motley Fool
Why BELLUS Health Stock Is Rocketing Higher Today
April 18, 2023
A $2 billion buyout agreement with GSK is lighting a fire under the biotech's stock today.
Via
The Motley Fool
Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal
April 18, 2023
Shares of its takeover candidate nearly doubled on the news.
Via
Investor's Business Daily
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
April 18, 2023
On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide.
Via
Benzinga
Tesla, Windtree Therapeutics, Enovix Corp, Moderna, Blackboxstocks: Why These 5 Stocks Are Drawing Investors' Attention Today
April 17, 2023
Via
Benzinga
These 2 Stocks Were Monday's Big Disappointments
April 17, 2023
On a good day for the market, investors weren't happy about these decliners.
Via
The Motley Fool
S&P 500: Top 5 Performers Today Include Enphase Energy, First Solar
April 17, 2023
M&T Bank was the S&P 500's top performer. State Street was the biggest loser.
Via
Investor's Business Daily
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
April 17, 2023
A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.
Via
The Motley Fool
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.